NATIONAL HEALTHCARE CORP 10-Q

Item 4. Controls and Procedures .   As of September 30, 2020, an evaluation was performed under the supervision and with the participation of the Company’s management, including the Chief Executive Officer (“CEO”) and Principal Accounting Officer (“PAO”), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures. Based on that evaluation, the Company’s management, including the CEO and PAO, concluded that the Company’s disclosure controls and procedures were effective as of September 30, 2020.   38 Table of Contents    PART II. OTHER INFORMATION     Item 1. Legal Proceedings.   For a discussion of prior, current, and pending litigation of material significance to NHC, please see Note 16 of this Form 10–Q.